SM-6586 is used as a calcium channel antagonist and inhibitor of Na⁺/H⁺ and Na⁺/Ca²⁺ exchange transport; it is primarily employed in the study of cerebrovascular diseases and hypertension. In vivo studies show that SM-6586 improves survival rate, reduces brain water content, increases ATP levels, decreases lactate levels in spontaneously hypertensive rats after bilateral common carotid artery ligation, and reduces T1 relaxation time in focal ischemia models.